Physician profile
Alejandro Sanchez
NPI 1619561586
$63,917.46
in general payments reported to CMS, 2019-2025
24 companies · $28K in 2025
The $28K reported for 2025 was more than what 92% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,825 · 2022: $5,306 · 2023: $3,691 · 2024: $25K · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $28K · Travel and Lodging: $17K · Food and Beverage: $11K · Education: $941.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $28,000.00 |
| Travel and Lodging | $16,642.32 |
| Food and Beverage | $11,203.93 |
| Education | $940.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $27,117.25 | 2024-2025 | Tacticath, Assurity, Ensite |
| Medtronic, INC. | $20,081.68 | 2021-2025 | Micra, Azure Xt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan |
| Biotronik INC. | $6,951.80 | 2021-2025 | Acticor 7 Vr-T Dx, Biomonitor |
| Boston Scientific Corporation | $4,518.70 | 2021-2025 | Farapulse, Watchman Access System, Watchman |
| Biosense Webster, INC. | $3,064.75 | 2022-2025 | Carto 3 |
| Atricure, INC. | $378.38 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Novartis Pharmaceuticals Corporation | $378.24 | 2021-2024 | Leqvio |
| Philips North America LLC | $244.82 | 2025 | Igt Devices Undivided, Mechanical Tools, Lm Accessories |
| Amgen INC. | $215.38 | 2022-2023 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $179.51 | 2022-2023 | Jardiance |
| Becton, Dickinson and Company | $124.22 | 2025 | Hemosphere |
| Cardiva Medical, INC. | $124.14 | 2022-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Astellas Pharma US INC | $122.83 | 2022 | |
| Pfizer INC. | $105.74 | 2021-2025 | |
| Edwards Lifesciences Corporation | $60.51 | 2024 | Hemosphere |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $50.43 | 2022-2023 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $39.86 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $33.62 | 2024 | Uptravi |
| Vital Connect, INC | $25.56 | 2023 | Vitalpatch Rtm |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.16 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $20.39 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $20.19 | 2022 | |
| Terumo Medical Corporation | $19.99 | 2022 | |
| Novo Nordisk INC | $15.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alejandro Sanchez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.